• No results found

2015 Annual Convention

N/A
N/A
Protected

Academic year: 2021

Share "2015 Annual Convention"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

(1)

2015 Annual Convention

Date: Monday, October 12, 2015

Time: 8:00 am – 9:30 am

Location: Gaylord National Harbor Resort and Convention Center, National Harbor 3

Title: How to Create a Specialty Pharmacy Presence for Your Community Pharmacy

ACPE # 207-000-15-118-L04-P  0.15 CEUs ACPE # 207-000-15-118-L04-T

Activity Type: Application-based

Speaker: Aaron Clark, PharmD, Blount Discount Pharmacy

Frank Steed, RPh, Gerould’s Pharmacies, Inc. Jonathan Grice, PharmD, HomeTown Pharmacy Kevin Day, PharmD, Executive Resident, NCPA

Pharmacist and Pharmacy Technician Learning Objectives:

Upon completion of this activity, participants will be able to:

1. Discuss the specialty marketplace, how independent pharmacy fits into the marketplace, and what capabilities are required to participate.

2. Identify barriers to entry for an independent pharmacy looking into specialty pharmacy.

3. Discuss options available for independent pharmacies to obtain capabilities of a specialty pharmacy.

Disclosures:

Aaron Clark declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

Frank Steed declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

Jonathan Grice declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

Kevin Day declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

NCPA’s education staff declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

(2)
(3)

• http://www.drugstorenews.com//article/dsntv-ncpa- forum-touts-community-pharmacy-role-specialty-rx-part-1?sid=43640 How to Create a Specialty Pharmacy

Presence for Your Community Pharmacy

Kevin Day has no financial conflicts to disclose. Aaron Clark has no financial conflicts to disclose. Frank Steed is a customer of Aureus Health Services. Jonathan Grice is a customer of KloudScript, Inc.

These potential conflicts of interest have been resolved by peer review of the slides.

(4)

1. Discuss the specialty marketplace, how independent pharmacy fits into the marketplace, and what capabilities are required to participate. 2. Identify barriers to entry for an independent

pharmacy looking into specialty pharmacy. 3. Discuss options available for independent

pharmacies to obtain capabilities of a specialty pharmacy.

Learning Objectives

What is Specialty??

• Manufacturers and Payers are ‘defining’ specialty

• Manufacturers:

– Limited Distribution Drugs – Closed and Limited Networks

• Payers:

– Fourth Tier for Medications – Specialty Pharmacy Networks – Prior Authorization

(5)

• In general, “Specialty Medications” have most of the following characteristics:

– High cost

– Indicated for the treatment of a chronic, rare illness – Injectable or infused

– Complex manufacturing

– Special storage and handling requirements

– Complex monitoring for patient compliance, persistence, and side effects

• Many treat Cancer, Multiple Sclerosis, Genetic Disorders, Infectious Diseases, and Auto-Immune/Inflammatory Diseases Specialty Specialty SPECIALTY DRUG SPEND AMOUNT AND PERCENT OF TOTAL DRUG SPEND* $92B $127B $179B $235B 30% 38% 45% 50% 0% 10% 20% 30% 40% 50% 60% $0 $50 $100 $150 $200 $250 $300 2012 2014** 2016** 2018** Percen t of  To ta l Dr ug  Spe n d Spe cialty  Dr ug  Spe n d  (billio ns ) *Includes medical and pharmacy benefit spending. **Projected Source: CVS Health. “2014 Insights Report.” 2014.  http://www.cvshealth.com/2014‐insights‐report‐specialty‐drives‐trend

• Specialty pharmacy is a set of services

– Patient management – Adherence support

– Data collection, aggregation, and reporting

• Specialty pharmacies have demonstrated the capabilities to efficiently and effectively provide these services

(6)

• So how does an independent become a specialty pharmacy?

– You might be able to just call yourself one! • More likely…

– Look for a partner

– Build the capabilities yourself – Achieve accreditation

Specialty Pharmacy

• Partners:

– Several companies are helping independent pharmacies participate in the specialty pharmacy marketplace – They offer a variety of solutions for pharmacies

Specialty Pharmacy

• Challenges for Independent Pharmacies

– Marketing – Workflow – Staffing – Financials – Contracting – Accreditation Specialty Pharmacy

(7)

Aaron Clark, PharmD Blount Discount

Pharmacy [email protected]

Quality Care Specialty Program

Frank Steed, RPh Gerould’s Pharmacy

[email protected]

What is a Specialty Pharmacy? • A pharmacy that manages “high cost” drugs that often

require special handling and additional pharmacy (or clinical) support

• Many are complex biologics and injectable drugs

• Specialty drugs are used to treat serious or chronic medical conditions such as: Multiple Sclerosis, Hemophilia, Chronic Hepatitis C, Rheumatoid and Psoriatic Arthritis, and Cancer

(8)

28.9 26.8 25.6 13.8 26.1 25.4 11.1 14.3 8.9 7.7 12.5 6.1 10.4 11.4 22.2 9.4 17.9 11.3 13.0 15.1 22.6 24.1 25.6 27.9 32. 2010 = 75.8 2011 = 83.3 2012 = 89.5 2013 = 98.1 2014 = 124.1 Oncology Autoimmune HIV Antivirals Multiple Sclerosis Viral Hepatitis Other Specialty Medicines

Source: IMS Health, National Sales Perspectives, Dec 2014

Spending on Specialty Medicines US$Bn

22.6 11.3 9.4 6.1 25.4 24.1 13.0 10.4 25.6 7.7 26.1 25.6 8.9 11.4 15.1 14.3 28.9 26.8 11.1 12.5 17.9 22.2 32.6 27.9 13.8 12.3

Specialty Medications Now Account for 1/3 of Drug Spend

Top 10 Specialty Drugs 2014

Rank Drug Name Therapy Class 1 Humira®(adalimumab) Inflammatory Conditions

2 Enbrel®(etanercept) Inflammatory Conditions

3 Sovaldi®(sofosbuvir) Hepatitis C 4 Copaxone® (glitiramer) Multiple Sclerosis

5 Tecfidera®(dimethyl fumarate) Multiple Sclerosis

6 Avonex®(interferon beta-1a) Multiple Sclerosis

7 Atripla®(efivirenz/emtricitabine/tenofovir) HIV 8 Gleevec®(imatinib) Oncology 9 Revlimid®(lenalidomide) Oncology 10 Olysio®(simeprevir) Hepatitis C

• Extensive infrastructure need - technology and resources are needed • Complexity of operations – comprehensive BI and PA support • Access to products – manufacturers are limiting access to specialty drugs • Clinical outcomes need – payers / manufacturers may require clinical

outcome reporting

• Technology – need a scalable pharmacy platform which is costly • Payer contracts – limit ability to fill specialty medications due to network

lock out

(9)

• Identify a specialty partner for the short and long term

• What will bridge the gap?

Marketing and Technology

Overcoming Challenges

Shorter Term

• Retail pharmacies keep 

more specialty patients

• Fill more specialty Rx’s

• Build specialty patient base

Longer Term • Create a value proposition  to prescribers • Obtain new Pharma  revenue streams • Increase access to specialty  drugs and payer contracts

An Investment For The Future

• Specialty is NOT a Pot of GOLD!

• Specialty Pharmacy is work, it is a commitment

you make with a cost for success

• Accreditation (cost to get accredited)

• LDD access, getting and keeping access (reporting)

• Network contracts, will you accept the contract pricing?

• You get contracted, can you stay contracted? Contract

requirements and reporting

• Specialty needs to be marketed, just because you build

it doesn’t mean they will come

• Obtained prior authorization for Hepatitis C drugs for retail store

• Coordinated overrides utilizing AWP (Any Willing Provider laws) & AMMO Bill for Medicare Part D and NY Managed Medicaid

• Refill management

• Just-in-time inventory management for pharmacy client which helps eliminate the possibility of returns

(10)

• You need to search for a partner that has similar goals and will meet the needs for your investment

• Consider your commitment to specialty, it is not meant for everyone

• Your ability to succeed will depend on your investment of both capital and time

• Select your partner for the long term

Picking a Partner for Specialty

Hometown Pharmacy Specialty Care Program

In Partnership With  KloudScript

Jonathan Grice, PharmD

Hometown Pharmacy Profile

Founded in 1996 • Family owned & operated • 36 Retail Locations • 34 Michigan, 2 Indiana Management Team

• Fred Grice, President • Jim Grice, Vice President • Anna Rider, Vice President • Jon Grice, Director of Retail &

Specialty Pharmacy MISSING PIECE = 

Advanced Retail Practice •Immunizations & Travel Vaccinations •Point of Care Testing •Medication Therapy Management •Compounding & HRT consultations •Durable Medical Equipment •Home Medical Equipment •Vitamin and Nutritional Supplements •Home Delivery Service •Compliance Packaging

(11)

Challenging Times . . . Blockbuster  Brand Patent  Cliff Increasing  Generic  Market Share Exclusion  From Growing  SP Pipeline Getting into Specialty is a MUST! PROFITS

Our Criteria For Specialty Solution

 Buy or Build?  Not attractive

 High risk, high expense, resource intensive,  Lack of scale

 Select the Right Partner!!!  Low risk solution  Low upfront capital solution  Partner who did not compete with us

 Partner that will not sellout to a competitor or mass merchant  Comprehensive program designed for community pharmacies

(not just accidental Specialty RXs)  Partnership beyond back office support  Aligned for long term growth & success

Our Partner . . . • Turn-Key Solution • Faster ROI • De Minimis Investment • Full Services Program Support • Robust Technology Enabled Processes • Local Sales & Marketing

National Network Accreditation Data Analytics Operational  Compliance & QA SCALE FOR PAYOR  AND PHARMA!

(12)

Together, We Redefine Specialty Care! ACCESS FRAMEWORK TECHNOLOGY TRAINING HUB SERVICES DRUG  FULFILLMENT PATIENT  ENGAGEMENT PHARMACY PARTNER

Growth Since Launch

0 100 200 300 400 500

SCRIPTS REVENUE GROSS PROFIT

Percent 288% Performance Metrics (September 2014 to August 2015)  332% 458% Our partnership consistently demonstrates  that local care benefits patients and prescribers.   Together we are earning their business! Together, We Redefine Specialty Care! Questions?

(13)

References

Related documents

Chetty describes his recent work with Nathaniel Hendren, Patrick Kline, and Emmanuel Saez, which has documented upward mobility rates for 741 metropolitan and rural areas

Of the seven South Australian policy documents, older people are referenced in rela- tion to mental health in two specific mental health documents ( South Australia’s Mental Health

This paper delves into the experiences and motivational orientations of Jamaican smallholder farmers to make a contribution to the literature about the heterogeneity among the

For beech high forests, the management approach which has been described for private properties in Southern Italy, based on the opening of very small

If the LBD externality is embodied in aggregate investment, the optimal policy calls for subsidizing the cost of capital in the traded sector, and there is no room for

Opportunities to increase cereal production by 2050 on current cereal land were estimated through extrapolation of 1991 – 2014 increases in actual yields and different levels (50%

predictions may have not been precise (only exactly predicting less than a third of all changes), the model does capture the general spatial distribution of land use